Skip to content
Screener

AngioDynamics ANGO Net debt / EBITDA

Net debt / EBITDA at other companies

Abbott logo
AbbottABT
2.5×+1.9×
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
2.9×-1.0×
TFX
TeleflexTFX
9.4×+5.5×
Stryker logo
StrykerSYK
1.9×-1.3×
Merit Medical Systems logo
Merit Medical SystemsMMSI
1.1×-0.5×
ICU Medical logo
ICU MedicalICUI
3.7×-0.3×

Other financials

Income statement

See full
Revenue$86.6M+8.0%
Gross profit$46.8M+10.8%
Operating income-$10.2M-76.1%
Net income-$11.4M-88.5%
EPS (diluted)-$0.27-80.0%

Balance sheet

See full
Cash & equivalents$53.9M-3.6%
Total debt$11.0M+8.0%
Total equity$170.8M-6.6%
Total assets$267.2M-4.6%

Cash flow

See full
Operating cash flow$17.5M—
CapEx$413.0K-46.8%
Free cash flow$17.0M—

Valuation

See full
Market cap$648.51M+88.9%
Enterprise value$605.6M+103%
P/S2×+0.9×

Profitability

See full
Gross margin54.6%+0.7pp
Operating margin-12.5%-1.0pp
Net margin-11.5%-0.1pp
FCF margin0.2%—

Returns & leverage

See full
Return on equity-20.8%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.2×0.0×

Where this comes from

Calculated from AngioDynamics’s reported figures.

net debt/ebitda=-2.7×

Based on the most recent quarter.

The source filing: AngioDynamics’s 10-Q, filed January 8, 2024. Open the filing →

Filed
Jan 8, 2024
Fiscal quarter
Q2 FY2024
Calendar quarter
Q4 2023
Accession
0001628280-24-000857

FAQ

What is AngioDynamics's net debt / EBITDA?
AngioDynamics (ANGO) reported net debt / EBITDA of -2.7× in Q3 2023.
What does net debt / EBITDA mean?
Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.

Ask your AI about AngioDynamics's net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude